08-25-08 People to know in bioscience - Bizjournals
08-25-08 $26.5M incentive could propel bioscience industry - Bizjournals
08-25-08 Deal gives VC-owned firms a shot at research awards - Bizjournals
08-25-08 Bomb attacks light a fire under proposed legislation - Bizjournals
08-25-08 LiquaJet introduces liquid nitrogen milling technology - Bizjournals
08-25-08 Gilead’s hiring plan: 1,900 new jobs - Bizjournals
08-25-08 UH researcher presses case to clear his name - Bizjournals
08-25-08 Contenders for National Bio and Agro-Defense Facility - Bizjournals
08-25-08 National Bio and Agro-Defense Facility would add to ‘magnet’ of K-State’s Olathe campus - Bizjournals
08-25-08 Region will win if Manhattan gets National Bio and Agro-Defense Facility - Bizjournals
08-25-08 Proposed National Bio and Agro-Defense Facility in Manhattan - Bizjournals
08-25-08 WFU ready to launch its bioethics master's degree - Bizjournals
08-25-08 Osceola wooing medical research lab, 25 high-wage jobs - Bizjournals
08-25-08 ATI now ready to pounce on biotech - Bizjournals
08-22-08 NeurogesX signs supply deal with Taiwanese company - Bizjournals
08-22-08 Neurogesx signs supply deal with Taiwanese company - Bizjournals
08-22-08 NeurogesX signs supply deal with Taiwanese company - Bizjournals
08-22-08 Neurogesx signs supply deal with Taiwanese company - Bizjournals
08-22-08 BioTime makes additional licensing agreement with Advanced Cell - Bizjournals
08-22-08 BioTime makes additional licensing agreement with Advanced Cell - Bizjournals
08-19-08 Advanced Cancer Therapeutics appoints chief scientific officer - Bizjournals
08-19-08 Former Georgia Tech worker gets jail time for mail fraud - Bizjournals
08-19-08 Advanced Cancer Therapeutics appoints chief scientific officer - Bizjournals
08-19-08 Former Georgia Tech worker gets jail time for mail fraud - Bizjournals
08-18-08 Prestwick Pharmaceuticals sends drug to market this year - Bizjournals
08-18-08 Cell Therapeutics Q2 loss: $59M - Bizjournals
08-18-08 Evestra raises $4.35 million in inaugural offering - Bizjournals
08-18-08 UTSA wins NIH-funding for neurological research - Bizjournals
08-18-08 Stanford scientists suggest stem-cell monkey-wrench - Bizjournals
08-18-08 Stanford stem-cell study: Human therapy may be limited - Bizjournals
08-18-08 Stanford stem-cell study: human therapy may be limited - Bizjournals
08-18-08 Prestwick Pharmaceuticals sends drug to market this year - Bizjournals
08-18-08 Cell Therapeutics Q2 loss: $59M - Bizjournals
08-18-08 Evestra raises $4.35 million in inaugural offering - Bizjournals
08-18-08 UTSA wins NIH-funding for neurological research - Bizjournals
08-18-08 Stanford scientists suggest stem-cell monkey-wrench - Bizjournals
08-18-08 Stanford stem-cell study: Human therapy may be limited - Bizjournals
08-18-08 Stanford stem-cell study: human therapy may be limited - Bizjournals
08-18-08 A wet blanket on life sciences - Bizjournals
08-18-08 Snakes alive: Hiberna seeks help from nature to cure many diseases - Bizjournals
08-18-08 Businesses’ loss could be state’s gain - Bizjournals
08-18-08 Lions Eye Institute sees research in its future - Bizjournals
08-18-08 New and improved - Bizjournals
08-18-08 With IPO on ice, Biolex raises $3.3M - Bizjournals
08-18-08 Biotech firms seek support - Bizjournals
08-18-08 ‘Color Purple’ raising issues; MCW prof perfect - Bizjournals
08-18-08 The Insider - Bizjournals
08-18-08 Mirina Corp. targets genetic research field of microRNA to develop new class of drug ther - Bizjournals
08-18-08 Slowdown in NIH funding creates 'quiet crisis' - Bizjournals
08-18-08 Cancer vaccine trial results fail to boost Accentia stock - Bizjournals
08-18-08 Transnetyx to double test volume - Bizjournals
08-18-08 FDA attempts to streamline its drug pipeline with hires - Bizjournals
08-18-08 A wet blanket on life sciences - Bizjournals
08-18-08 Snakes alive: Hiberna seeks help from nature to cure many diseases - Bizjournals
08-18-08 Businesses’ loss could be state’s gain - Bizjournals
08-18-08 Lions Eye Institute sees research in its future - Bizjournals
08-18-08 New and improved - Bizjournals
08-18-08 With IPO on ice, Biolex raises $3.3M - Bizjournals
08-18-08 Biotech firms seek support - Bizjournals
08-18-08 ‘Color Purple’ raising issues; MCW prof perfect - Bizjournals
08-18-08 The Insider - Bizjournals
08-18-08 Mirina Corp. targets genetic research field of microRNA to develop new class of drug ther - Bizjournals
08-18-08 Slowdown in NIH funding creates 'quiet crisis' - Bizjournals
08-18-08 Cancer vaccine trial results fail to boost Accentia stock - Bizjournals
08-18-08 Transnetyx to double test volume - Bizjournals
08-18-08 FDA attempts to streamline its drug pipeline with hires - Bizjournals
08-15-08 Boston Scientific recalls stents due to defect - Bizjournals
08-15-08 Report: Analysts peg final Genentech price at $107.50 per share - Bizjournals
08-15-08 Report: Analysts peg Genentech price at $107.50 a share - Bizjournals
08-15-08 MicroMet shows promise with latest test results - Bizjournals
08-15-08 Report: Analysts peg Genentech price at $107.50 a share - Bizjournals